RT Journal Article
SR Electronic
T1 Risk of hospitalization and risk of death for healthcare workers with COVID-19 in nine European Union/European Economic Area countries, January 2020–January 2021
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.01.21252651
DO 10.1101/2021.03.01.21252651
A1 Ferland, Lisa
A1 Dias, Joana Gomes
A1 Carvalho, Carlos
A1 Adlhoch, Cornelia
A1 Suetens, Carl
A1 Beauté, Julien
A1 Kinross, Pete
A1 Plachouras, Diamantis
A1 Lamb, Favelle
A1 Hannila-Handelberg, Tuula
A1 Fabiani, Massimo
A1 Riccardo, Flavia
A1 Mossong, Joël
A1 Vergison, Anne
A1 van Gageldonk-Lafeber, Rianne
A1 Teirlinck, Anne
A1 Melillo, Jackie
A1 Melillo, Tanya
A1 Mook, Piers
A1 Pebody, Richard
A1 Rehse, Ana Paula Coutinho
A1 Monnet, Dominique L.
YR 2021
UL http://medrxiv.org/content/early/2021/03/08/2021.03.01.21252651.abstract
AB We assessed the impact of COVID-19 on healthcare workers (HCWs) from data on 2.9 million cases reported from nine countries in the EU/EEA. Compared to non-HCWs, HCWs had a higher adjusted risk of hospitalization (IRR 3.0 [95% CI 2.2-4.0]), but not death (IRR 0.9, 95% CI 0.4-2.0).Article Summary Line Healthcare workers are hospitalized more frequently than non-healthcare workers when adjusting for age, sex, and comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementECDC and WHO internal fundsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript evaluates de-identified public health surveillance data. Actions taken for public health or clinical purposes, and not for research purposes, are not research procedures and do not require IRB approval before being implemented.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are publicly available through https://www.ecdc.europa.eu